Stock Events

Stock Events

Chromocell Therapeutics (CHRO) Q2 2024 Earnings

May 15Confirmed

Q1 1

Q2 2024

-2.9

-2.12

-1.33

-0.55

Details

Expected EPS

N/A

Actual EPS

-0.55

Surprise EPS

N/A

Surprise Percent

N/A

Description

⁨Chromocell Therapeutics⁩ (⁦CHRO⁩) has reported earnings of ⁦-0.55⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.